European Heart Journal Advance Access originally published online on July 4, 2006
European Heart Journal 2006 27(15):1773-1777; doi:10.1093/eurheartj/ehl123
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Treatment of chronic heart failure: a comparison between the major guidelines
1 Department of Cardiology, Western Infirmary, Dumbarton Road, Glasgow G11 6NT, Scotland, UK
2 Department of Emergency and Cardiovascular Medicine, Sahlgrenska Academy, Göteborg University, Göteborg, Sweden
3 Department of Medicine, Sahlgrenska University Hospital/Östra, 416 45 Göteborg, Sweden
Received 6 June 2006; accepted 8 June 2006; online publish-ahead-of-print 4 July 2006.
* Corresponding author. Tel: +44 141 211 1838; fax: +44 141 211 2252. E-mail address: j.mcmurray{at}bio.gla.ac.uk
Abstract
Because of rapid advances in the treatment of chronic heart failure, four important guidelines, including those from the European Society of Cardiology, have recently been updated. This review compares and contrasts the levels of evidence and classes of recommendation given to each of the key pharmacological and device therapies advocated by these guidelines. Possible explanations for discrepancies between the guidelines are discussed. Future approaches that might clarify the grade of evidence allocated and class of recommendation made are also described.
Key Words: Heart failure Guidelines ACE inhibitor Beta-blocker Angiotensin receptor blocker Aldosterone antagonist
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Swedberg {beta}-Blockers in worsening heart failure: good or bad? Eur. Heart J., September 2, 2009; 30(18): 2177 - 2179. [Full Text] [PDF] |
||||
![]() |
J. J.V. McMurray, C. B. Granger, J. Ostergren, S. Yusuf, M. A. Pfeffer, and K. Swedberg Dual Renin-Angiotensin system blockade in heart failure. J. Am. Coll. Cardiol., July 14, 2009; 54(3): 278 - 278. [Full Text] [PDF] |
||||
![]() |
M. Komajda Heart failure guidelines in North America and Europe: agreement or disagreement? Eur J Heart Fail Suppl, April 1, 2009; 8(suppl_1): i11 - i14. [Full Text] [PDF] |
||||
![]() |
K. Swedberg Tailoring therapy in chronic heart failure Eur J Heart Fail Suppl, April 1, 2009; 8(suppl_1): i25 - i29. [Full Text] [PDF] |
||||
![]() |
P. Tricoci, J. M. Allen, J. M. Kramer, R. M. Califf, and S. C. Smith Jr Scientific Evidence Underlying the ACC/AHA Clinical Practice Guidelines JAMA, February 25, 2009; 301(8): 831 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Swedberg Pure heart rate reduction: further perspectives in heart failure Eur. Heart J. Suppl., September 1, 2007; 9(suppl_F): F20 - F24. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ekman and K. Swedberg Patients' Persistence of Evidence-Based Treatment of Chronic Heart Failure: A Treatment Paradox Circulation, August 14, 2007; 116(7): 693 - 695. [Full Text] [PDF] |
||||
![]() |
G. Filippatos and D. T. Kremastinos Beta-blockers in asymptomatic dilated cardiomyopathy: to b-block or not to b-block? Eur. Heart J., May 1, 2007; 28(9): 1170 - 1171. [Full Text] [PDF] |
||||





